Form 4: Heron Therapeutics, Inc. /De/ CEO Reports Stock Transaction
Insider Transaction (Form 4)
Craig A Collard, Chief Executive Officer and a Director of Heron Therapeutics, Inc. /De/, reported multiple transactions in common stock on July 30, 2026.
Summary
- Option exercise/conversion: acquired 50,021 Common Stock on July 30, 2026; holds 821,703 after (Direct).
- Option exercise/conversion: acquired 34,789 Common Stock on July 31, 2026; holds 856,492 after (Direct).
- Option exercise/conversion: disposed of 50,021 Restricted Stock Units on July 30, 2026; holds 700,295 after (Direct).
- Option exercise/conversion: disposed of 34,789 Restricted Stock Units on July 31, 2026; holds 347,886 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Craig A Collard — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-30 | Option exercise/conversion | Common Stock | 50,021 | — | — | 821,703 |
| 2026-07-31 | Option exercise/conversion | Common Stock | 34,789 | — | — | 856,492 |
| 2026-07-30 | Option exercise/conversion | Restricted Stock Units | 50,021 | — | — | 700,295 |
| 2026-07-31 | Option exercise/conversion | Restricted Stock Units | 34,789 | — | — | 347,886 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-30 | Option exercise/conversion (50,021 shares) |
| 2026-07-31 | Option exercise/conversion (34,789 shares) |
| 2026-07-30 | Option exercise/conversion (50,021 shares) |
| 2026-07-31 | Option exercise/conversion (34,789 shares) |
Keywords
insider transaction, Form 4, HRTX, HERON THERAPEUTICS, INC. /DE/, neutral, Craig A Collard
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.